A University of California, Riverside, study that sought to determine barriers to health care among Spanish-speaking Latino farmworkers in rural communities has devised an innovative health care service delivery model that addresses many challenges these communities face. The researchers, led by Ann Cheney, a medical anthropologist and assistant professor in...

Budget allocates ongoing funding to the medical school

The Chinese Americans Donation Center also donated 1,000 face shields to the School of Medicine

UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells

UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task

Research supported by five-year NIH grant may have relevance for COVID-19 patients

The first class of fellows begins training in the Coachella Valley’s Betty Ford Center and Eisenhower Medical Center on July 1

UC Riverside-led study calls for culturally tailored approaches to encourage this neglected population to seek behavioral health treatment

UC Riverside biomedical scientist Marcus Kaul explains

Telehealth visits can be conducted on a cell phone, tablet, or pad device, allowing even individuals without a computer or internet to be seen by a UCR Health physician

Brandon Brown is an associate professor in the Center for Healthy Communities in the School of Medicine

Scientists discover critical protein complex that lets virus hide from immune system

Nearly 70 graduates were accepted into residency programs of their choice in 2020

UC Riverside School of Medicine to lead engagement project in eastern Coachella Valley

Drugs previously in development for SARS could be effective for COVID-19

Brandon Brown is an associate professor in the School of Medicine at UC Riverside

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

Additional ongoing funding would help the medical school expand enrollment

UC Riverside research is supported by a four-year grant worth more than $1.2 million

UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut